DEFINITIVE PROXY

Company

CNS Pharmaceuticals, Inc.

Filed

June 8, 2021

Period of Report

June 28, 2021

Accession Number

0001683168-21-002410

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →